Concurrent Chemoradiotherapy Combined With Immunotherapy in Patients With Potentially Resectable Pancreatic Cancer
Clinical trial NCT05634564 · UNKNOWN
Trial details
- NCT number
- NCT05634564
- Sponsor
- The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-01
- Primary completion
- 2023-04-01
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.